Kungoldingen, Switzerland

Rene Gnehm

This inventor holds 5 USPTO granted patents. Top assignee: Siegfried Aktiengesellschaft. Active years: 1980-1987.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • K/u/ ngoldingen, CH (1985)
  • Kungoldingen, CH (1980 - 1987)

Company Filing History:


Years Active: 1980-1987

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Rene Gnehm

Introduction

Rene Gnehm is a notable inventor based in Kungoldingen, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory drugs. With a total of five patents to her name, Gnehm's work exemplifies innovation and dedication to improving healthcare.

Latest Patents

Gnehm's latest patents include a method for the production of acemetacin, specifically 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid carboxymethyl ester. This method involves a novel and simpler approach that utilizes mild acid hydrolysis of 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetoxyacetic tetrahydropyran-2-yl ester. The final product is recognized as a valuable drug with anti-inflammatory activity. Another patent focuses on the production of acemetacin, specifically 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indole acetic acid. This method also employs a novel approach, hydrolizing 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indole acetic acid tetrahydropyranyl ester, which is a new compound. The resulting product is similarly valuable for its anti-inflammatory properties.

Career Highlights

Gnehm is currently employed at Siegfried Aktiengesellschaft, where she continues to innovate in the pharmaceutical industry. Her work has not only advanced drug development but has also contributed to the overall understanding of anti-inflammatory treatments.

Collaborations

Throughout her career, Gnehm has collaborated with esteemed colleagues such as Rolf Weber and Hans-Rudolf Marti. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Rene Gnehm's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her importance as an inventor. Her work continues to pave the way for advancements in anti-inflammatory treatments, showcasing the vital role of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…